How we support drug discovery research
At Cancer Research UK we have a strong track record of therapeutic discovery. And thanks to our extensive portfolio of basic research and our strengths in drug development, we ensure that innovation in cancer treatment benefits patients sooner.
To support translational research we fund investigator-led projects and programmes through our Drug Discovery Committee:
We have also made extensive investment in the infrastructure of drug discovery, and our specialist laboratories are available to support CRUK researchers.
The CRUK-MEDI Alliance Laboratory is accelerating the translation of cancer research into potential new biotherapeutic drugs. This innovative collaboration with AstraZeneca's global biologics research and development arm enables CRUK researchers to access MedImmune's capabilities and technology.
Cancer Research UK Drug Discovery Units
Our core-funded Drug Discovery Units have an extensive experience and diverse expertise in small molecule drug discovery. CRUK researchers seeking to translate their research are encouraged to build collaborations with appropriate drug discovery groups.
We're driving discovery research in immuno-oncology which is leading to novel and exciting immunotherapeutic possibilities.
Translating today’s science into tomorrow’s medicine
Find out more about our extensive portfolio and infrastructure for drug discovery and development
Beating cancer from within
Find out why we’re investing in a platform for immunotherapy